Related Experiment Video
Updated: Nov 4, 2025

Advanced Glycation End-Products Sensitize Human Sensory-Like Neuron Cells to Capsaicin-Induced Calcium Influx
Published on: May 2, 2025
Enasidenib-induced Sweet syndrome with differentiation syndrome
1Department of Internal Medicine Rochester General Hospital Rochester NY USA.
Differentiation syndrome can mimic other serious conditions like sepsis or heart failure. Early recognition and treatment are crucial for a good prognosis in patients with differentiation syndrome.
Area of Science:
- Oncology
- Hematology
- Internal Medicine
Background:
- Differentiation syndrome is a potentially life-threatening complication of retinoid therapy for acute promyelocytic leukemia.
- It can present with a wide range of signs and symptoms that overlap with other critical conditions.
Purpose of the Study:
- To highlight the importance of recognizing differentiation syndrome.
- To differentiate it from other conditions that present similarly.
Main Methods:
- This abstract is based on clinical observations and established medical knowledge regarding differentiation syndrome.
- It emphasizes diagnostic vigilance and timely therapeutic intervention.
Main Results:
- Conditions such as drug rash, thromboembolism, sepsis, and heart failure can mimic the clinical presentation of differentiation syndrome.
- A high index of suspicion is necessary for accurate diagnosis.
Conclusions:
- Prompt and adequate treatment of differentiation syndrome leads to a favorable prognosis.
- Distinguishing differentiation syndrome from mimics is critical for effective patient management.
Related Concept Videos
The Physiology of Taste
Nephrotic Syndrome I : Introduction
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Diabetes: Symptoms, Diagnosis, and Complications
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

